HBIO vs BIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 21, 2026
HBIO
BIO
Investment Advisor Scores
BIO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HBIO | BIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.0602 | 38.61 | HBIO |
| PEG Ratio | 1.3059 | 1.1905 | BIO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.1% | -0.1% | HBIO |
| Earnings Growth | -80.3% | 18.7% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 41.0/100 | 37.1/100 | HBIO |
| Profit Margin | -11.9% | 8.6% | BIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HBIO
MarkupPrice above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71
BIO
MarkupPrice above SMA50, rising 50-day trend (7.9% over 20 days), RSI 78
Fundamentals Snapshot
| Metric | HBIO | BIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.6 | 37.9 |
| Trailing P/E | — | 44.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.6% | 0.5% |
| Operating Margin | 0.0% | 0.1% |
| EPS | -2.30 | 8.47 |
| Dividend Yield | — | — |